Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 8, 2026Reported sale · Form 4Chris Degnan, Chief Financial Officer · $80.8KOpen the filing ↗
- Oct 8, 2026Notice of sale · Form 144Christopher Degnan · Officer · $89.6KOpen the filing ↗
- Sep 8, 2026Reported sale · Form 4Jason Drew Smith, General Counsel · $64.6KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record53921 flagged findings
Reported transactions (Form 4)80since Jul 28, 2025
Corporate events (8-K)30since Jun 10, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-02Department of Justice inquiryrecentOpen filing ↗“…customarily included in these types of agreements occur. In accordance with the Agreement, the parties will terminate all…”
- 2026-05-06share offering or dilution eventrecentOpen filing ↗“…sales agreement (the “ATM Sales Agreement”) with TD Securities (USA) LLC (f/k/a Cowen and Company, LLC) (“TD Cowen”), pursuant to…”
+1 more passage from the same document
- “…a sales agreement (the “ATM Sales Agreement”) with TD Securities (USA) LLC (f/k/a Cowen and Company, LLC) (“TD Cowen”), pursuant to…”
- 2026-05-06Department of Justice inquiryrecentOpen filing ↗“…particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist…”
+1 more passage from the same document
- “…Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of…”
- 2026-03-02share offering or dilution eventrecentOpen filing ↗“…a sales agreement (the “ATM Sales Agreement”) with TD Securities (USA) LLC (f/k/a Cowen and Company, LLC) (“TD Cowen”), pursuant to…”
+1 more passage from the same document
- “…sales agreement (the “ATM Sales Agreement”) with TD Securities (USA) LLC (f/k/a Cowen and Company, LLC) (“TD Cowen”), pursuant to…”
- 2026-03-02Department of Justice inquiryrecentOpen filing ↗“…particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist…”
+1 more passage from the same document
- “…O ther Healthcare Regulations Our business activities, including but not limited to, research, sales, promotion,…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 539)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 9, 26Form 144 ↗Notice of proposed sale
- Oct 9, 26Form 4 ↗Insider transaction
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Sep 9, 26Form 144 ↗Notice of proposed sale
- Sep 9, 26Form 144 ↗Notice of proposed sale
- Aug 20, 268-K ↗Current report · Other events
- Aug 20, 26Form 144 ↗Notice of proposed sale
- Aug 12, 26SCHEDULE 13G/A ↗Passive stake · The Toronto-Dominion Bank · 6.7% · event on Jun 30, 26 · amendment
- Aug 5, 2610-Q ↗Quarterly report
- Aug 5, 268-K ↗Current report · Results
- Jul 10, 26Form 4 ↗Insider transaction
- Jul 9, 26Form 144 ↗Notice of proposed sale
Insider transaction · 7 Form 4 filingsshow all 7hide
- Jun 23, 268-K ↗Current report · A senior executive left or was appointed
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Jun 22, 26Form 144 ↗Notice of proposed sale
- Jun 9, 26Form 144 ↗Notice of proposed sale
539 filings on record, the oldest from Apr 1, 16.
Listing the 25 most recent filings of the 539 on record.
1719
- Jun 23, 26A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Mar 2, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Aug 27, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 3, 25A senior executive left or was appointed8-K 5.02 ↗
- Feb 20, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Oct 9, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 24, 24Took on a new financial obligation8-K 2.03 ↗
- Sep 13, 24A senior executive left or was appointed8-K 5.02 ↗
- Aug 8, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
3 material agreements entered2024show all 3hide
- Jun 18, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jan 17, 24Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jan 2, 24Entered a material agreement8-K 1.01 ↗
- Sep 11, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 27, 23Entered a material agreement+4 more in the same filing8-K 1.01 ↗
12 older filings not shown · The record reaches back to Jan 4, 19.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Fred Cohen1.9%Jun 5, 25SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Cowen Financial Products LLC6.9%Jun 30, 25SCHEDULE 13G/A ↗
- The Toronto-Dominion Bank6.7%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
- Morgan Stanley5.4%Jun 30, 25SCHEDULE 13G ↗
- BlackRock, Inc.5.2%Mar 31, 26SCHEDULE 13G ↗1 earlier filing
- Soleus Capital Master Fund, L.P.4.7%Jun 30, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show one more holderhide
- Paradigm BioCapital Advisors LP3.5%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Oct 8, Christopher Degnan filed notice of intent to sell up to $90K.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
No sale of theirs is on record yet in Form 4; the 90-day window is still open.
View notice (Form 144) ↗+5 more recent notices · 3 with a later sale
- Oct 8, 26Sell$81KChris DegnanChief Financial Officer↗
- Sep 8, 26Sell$65KJason Drew SmithGeneral Counsel↗
- Sep 8, 26Sell$37KMark SchoenbergChief Medical Officer↗
- Aug 20, 26Sell$2.9MMark SchoenbergChief Medical Officer↗
- Jul 9, 26Sell$400KMark SchoenbergChief Medical Officer↗
- Jun 22, 26Sell$350KMark SchoenbergChief Medical Officer↗
- Jun 8, 26Sell$143KMark SchoenbergChief Medical Officer↗
- May 8, 26Sell$300KMark SchoenbergChief Medical Officer↗
- Feb 3, 26Sell$36KMark SchoenbergChief Medical Officer↗
- Feb 3, 26Sell$36KMark SchoenbergChief Medical Officer↗
- Feb 3, 26Sell$73KMark SchoenbergChief Medical Officer↗
- Feb 3, 26Sell$52KJason Drew SmithGeneral Counsel↗
There are 7 more transactions in this stretch.
Stock compensation, tax and giftsshow the 21 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Oct 8, 26Compensationamount n/aChris DegnanChief Financial Officer↗
- Sep 7, 26Compensationamount n/aJason Drew SmithGeneral Counsel↗
- Sep 7, 26Compensationamount n/aMark SchoenbergChief Medical Officer↗
- Aug 26, 26Compensationamount n/aJames A. Robinson Jr.↗
- Jun 8, 26Compensationamount n/aMark SchoenbergChief Medical Officer↗
- May 26, 26Compensationamount n/aJames A. Robinson Jr.↗
- Jan 31, 26Compensationamount n/aMark SchoenbergChief Medical Officer↗
- Jan 31, 26Compensationamount n/aMark SchoenbergChief Medical Officer↗
- Jan 31, 26Compensationamount n/aMark SchoenbergChief Medical Officer↗
- Jan 31, 26Compensationamount n/aJason Drew SmithGeneral Counsel↗
- Jan 31, 26Compensationamount n/aJason Drew SmithGeneral Counsel↗
- Jan 31, 26Compensationamount n/aJason Drew SmithGeneral Counsel↗
- Nov 26, 25Compensationamount n/aDaniel George Wildman↗
- Nov 26, 25Compensationamount n/aLEANA WEN↗
- Nov 26, 25Compensationamount n/aJames A. Robinson Jr.↗
- Nov 26, 25Compensationamount n/aCYNTHIA M BUTITTA↗
- Nov 26, 25Compensationamount n/aStuart Holden↗
- Oct 8, 25Compensationamount n/aChris DegnanChief Financial Officer↗
- Sep 7, 25Compensationamount n/aJason Drew SmithGeneral Counsel↗
- Sep 7, 25Compensationamount n/aMark SchoenbergChief Medical Officer↗
- Jul 28, 25Compensationamount n/aMark SchoenbergChief Medical Officer↗
The full record holds 104 transactions and goes back to Mar 25, 22.
Its sector and its market
Urogen Pharma Ltd. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Urogen Pharma Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Urogen Pharma Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 539 documents on file, from Apr 1, 2016 to Oct 9, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.